Epigenetic modifications in reprogramming and lineage specifications from embryonic stem cells: Current trends and relevance in developing regenerative medicine

Stem Cell, Regenerative Medicine and Cancer

Volumn , Issue , 2011, Pages 3-29

  Han, Jinnuo ^a   Chung, Henry ^a   Sachdev, Perminder S ^a   Sidhu, Kuldip S ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84895257048     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (168)

1. Cowen, C. and A.M. Douglas, 'Stemness': Definitions, Criteria, and Standards, in Essentials of Stem Cell Biology. 2006, Elsevier Inc. p. xxv.
2. Graf, T. and M. Stadtfeld, Heterogeneity of Embryonic and Adult Stem Cells. Cell Stem Cell, 2008. 3(5): p. 480-483.
3. Hochedlinger, K. and K. Plath, Epigenetic reprogramming and induced pluripotency. Development, 2009. 136(4): p. 509-23.
4. Rao, M.S. and M.P. Mattson, Stem cells and aging: expanding the possibilities. Mechanisms of Ageing and Development, 2001. 122(7): p. 713-734.
5. Evans, M.J. and M.H. Kaufman, Establishment in culture of pluripotential cells from mouse embryos. Nature, 1981. 292(5819): p. 154-156.
6. Martin, G.R., Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proceedings of the National Academy of Sciences of the United States of America, 1981. 78(12 II): p. 7634-7638.
7. Bongso, A., et al., Fertilization and early embryology: Isolation and culture of inner cell mass cells from human blastocysts. Hum. Reprod., 1994. 9(11): p. 2110-2117.
8. Thomson, J.A., Embryonic stem cell lines derived from human blastocysts. Science, 1998. 282(5391): p. 1145-1147.
9. Sidhu, K.S., et al., Derivation of a new human embryonic stem cell line, Endeavour-2 and its characterization. In vitro Cellular and Development Biology, 2010. In press.
10. Sidhu, K.S., S. Walke, and B.E. Tuch, Current Protocols in Stem Cell BiologyDerivation and propagation of hESC under therapeutic environment. Vol. 6:1A.4.1-1A.4.31. 2008, USA: John Wiley and Sons.
11. Sidhu, K.S., J.P. Ryan, and B.E. Tuch, Derivation of a new hESC line, Endeavour-1 and its clonal propagation. Stem Cells and Devel., 2008. 17: p. 41-52.
12. Kurosawa, H., Methods for inducing embryoid body formation: in vitro differentiation system of embryonic stem cells. Journal of Bioscience and Bioengineering, 2007. 103(5): p. 389-398.
13. Klug, M.G., et al., Genetically selected cardiomyocytes from differentiating embryonic stem cells form stable intracardiac grafts. Journal of Clinical Investigation, 1996. 98(1): p. 216-224.
14. Li, M., et al., Generation of purified neural precursors from embryonic stem cells by lineage selection. Current Biology, 1998. 8(17): p. 971-974.
15. Soria, B., et al., Insulin-secreting cells derived from embryonic stem cells normalize glycemia in streptozotocin-induced diabetic mice. Diabetes, 2000. 49(2): p. 157-162.
16. Hadjantonakis, A.-K. and A. Nagy, The color of mice: in the light of GFP-variant reporters. Histochemistry and Cell Biology, 2001. 115(1): p. 49-58.
17. Kim, J.-H., et al., Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease. Nature, 2002. 418(6893): p. 50-56.
18. Shim, J.-W., et al., Enhanced In Vitro Midbrain Dopamine Neuron Differentiation, Dopaminergic Function, Neurite Outgrowth, and 1-Methyl-4-Phenylpyridium Resistance in Mouse Embryonic Stem Cells Overexpressing Bcl-XL. J. Neurosci., 2004. 24(4): p. 843-852.
19. Kanno, S., et al., Nitric oxide facilitates cardiomyogenesis in mouse embryonic stem cells. Proceedings of the National Academy of Sciences of the United States of America, 2004. 101(33): p. 12277-12281.
20. Kamochi, H., et al., Transplantation of myocyte precursors derived from embryonic stem cells transfected with IGFII gene in a mouse model of muscle injury. Transplantation, 2006. 82(4): p. 516-526.
21. Shiroi, A., et al., Differentiation of embryonic stem cells into insulin-producing cells promoted by Nkx2.2 gene transfer. World Journal of Gastroenterology, 2005. 11(27): p. 4161-4166.
22. Blyszczuk, P., et al., Expression of Pax4 in embryonic stem cells promotes differentiation of nestin-positive progenitor and insulin-producing cells. Proceedings of the National Academy of Sciences of the United States of America, 2003. 100(3): p. 998-1003.
23. Ishizaka, S., et al., Development of hepatocytes from ES cells after transfection with the HNF-3beta gene. The FASEB journal: official publication of the Federation ofAmerican Societies for Experimental Biology, 2002. 16(11): p. 1444-1446.
24. Li, X., et al., The transcription factor ZBP-89 controls generation of the hematopoietic lineage in zebrafish and mouse embryonic stem cells. Development, 2006. 133(18): p. 3641-3650.
25. Zhou, B.Y., et al., Inducible and reversible transgene expression in human stem cells after efficient and stable gene transfer. Stem Cells, 2007. 25(3): p. 779-789.
26. Vallier, L., M. Alexander, and R. Pedersen, Conditional gene expression in human embryonic stem cells. Stem Cells, 2007. 25(6): p. 1490-1497.
27. Hammond, S.M., et al., An RNA-directed nuclease mediates post-transcriptional gene silencing in Drosophila cells. Nature, 2000. 404(6775): p. 293-296.
28. Zaehres, H., et al., High-Efficiency RNA Interference in Human Embryonic Stem Cells. Stem Cells, 2005. 23(3): p. 299-305.
29. Matin, M.M., et al., Specific Knockdown of Oct4 and beta2-microglobulin Expression by RNA Interference in Human Embryonic Stem Cells and Embryonic Carcinoma Cells. Stem Cells, 2004. 22(5): p. 659-668.
30. Hyslop, L., et al., Downregulation of NANOG Induces Differentiation of Human Embryonic Stem Cells to Extraembryonic Lineages. Stem Cells, 2005. 23(8): p. 1035-1043.
31. Hohenstein, K.A., et al., Nucleofection Mediates High-Efficiency Stable Gene Knockdown and Transgene Expression in Human Embryonic Stem Cells. Stem Cells, 2008. 26(6): p. 1436-1443.
32. Niakan, K.K., et al., Novel role for the orphan nuclear receptor Dax1 in embryogenesis, different from steroidogenesis. Molecular Genetics and Metabolism, 2006. 88(3): p. 261-271.
33. Lickert, H., et al., Dissecting Wnt/β-catenin signaling during gastrulation using RNA interference in mouse embryos. Development, 2005. 132(11): p. 2599-2609.
34. Hiraoka-Kanie, M., M. Miyagishi, and J.K. Yamashita, Differentiation stage-specific analysis of gene function with inducible short hair-pin RNA in differentiating embryonic stem cells. Biochemical and Biophysical Research Communications, 2006. 351(3): p. 669-674.
35. Schmitt, T.M., et al., Induction of T cell development and establishment of T cell competence from embryonic stem cells differentiated in vitro. Nature Immunology, 2004. 5(4): p. 410-417.
36. Liu, H. and K. Roy, Biomimetic three-dimensional cultures significantly increase hematopoietic differentiation efficacy of embryonic stem cells. Tissue Engineering, 2005. 11(1-2): p. 319-330.
37. Liu, H., J. Lin, and K. Roy, Effect of 3D scaffold and dynamic culture condition on the global gene expression profile of mouse embryonic stem cells. Biomaterials, 2006. 27(36): p. 5978-5989.
38. Hwang, N.S., et al., Enhanced chondrogenic differentiation of murine embryonic stem cells in hydrogels with glucosamine. Biomaterials, 2006. 27(36): p. 6015-6023.
39. Hwang, N.S., et al., Effects of three-dimensional culture and growth factors on the chondrogenic differentiation of murine embryonic stem cells. Stem Cells, 2006. 24(2): p. 284-291.
40. Li, X.J., et al., Specification of motoneurons from human embryonic stem cells. Nature Biotechnology, 2005. 23(2): p. 215-221.
41. Shimada, H., et al., Differentiation of dopaminergic neurons from human embryonic stem cells: Modulation of differentiation by FGF-20. Journal of Bioscience andBioengineering, 2009. 107(4): p. 447-454.
42. Perrier, A.L., et al., Derivation of midbrain dopamine neurons from human embryonic stem cells. Proceedings of the National Academy of Sciences of the United States of America, 2004. 101(34): p. 12543-12548.
43. D'Amour, K.A., et al., Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells. Nat. Biotech, 2006. 24(11): p. 1392-1401.
44. Kroon, E., et al., Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo. Nat. Biotech, 2008. 26(4): p. 443-452.
45. Loeffler, M. and C. Potten, Stem cells and cellular pedigrees-- a conceptual introduction., in Stem cells, C. Potten, Editor. 1997, Academic Press: London. p. 1-27.
46. Alison, M. and S. Islam, Attributes of adult stem cells. The Journal of Pathology, 2009. 217(2): p. 144-160.
47. Bittner, R.E., et al., Recruitment of bone-marrow-derived cells by skeletal and cardiac muscle in adult dystrophic mdx mice. Anatomy and Embryology, 1999. 199(5): p. 391-396.
48. Mezey, E., et al., Turning Blood into Brain: Cells Bearing Neuronal Antigens Generated in Vivo from Bone Marrow. Science, 2000. 290(5497): p. 1779-1782.
49. Lagasse, E., et al., Purified hematopoietic stem cells can differentiate into hepatocytes in vivo. Nat. Med, 2000. 6(11): p. 1229-1234.
50. Bailey, A.S., et al., Transplanted adult hematopoietic stems cells differentiate into functional endothelial cells. Blood, 2004. 103(1): p. 13-19.
51. Gorin, N.-C., Autologous stem cell transplantation in hematological malignancies. Springer Seminars in Immunopathology, 2004. 26(1): p. 3-30.
52. Liu, Y. and M.S. Rao, Transdifferentiation - Fact or artifact. Journal of Cellular Biochemistry, 2003. 88(1): p. 29-40.
53. Raff, M., Adult stem cell plasticity: Fact or Artifact? Annual Review of Cell andDevelopmental Biology, 2003. 19(1): p. 1-22.
54. Turek-Plewa, J. and P.P. Jagodzinski, The role of mammalian DNA methyltransferases in the regulation of gene expression. Cellular and Molecular BiologyLetters, 2005. 10(4): p. 631-647.
55. Bird, A.P., CpG islands as gene markers in the vertebrate nucleus. Trends in Genetics, 1987. 3: p. 342-347.
56. Takai, D. and P.A. Jones, The CpG Island Searcher: A new www resource. In Silico Biology, 2003. 3(3): p. 235-240.
57. SchuÌ̂beler, D., et al., Genomic targeting of methylated DNA: Influence of methylation on transcription, replication, chromatin structure, and histone acetylation. Molecular and Cellular Biology, 2000. 20(24): p. 9103-9112.
58. Reik, W. and J. Walter, Genomic imprinting: parental influence on the genome. Nat.Rev. Genet, 2001. 2(1): p. 21-32.
59. Avner, P. and E. Heard, X-chromosome inactivation: counting, choice and initiation. Nat. Rev. Genet, 2001. 2(1): p. 59-67.
60. Irizarry, R.A., et al., The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores. Nat. Genet, 2009. 41(2): p. 178-186.
61. Straussman, R., et al., Developmental programming of CpG island methylation profiles in the human genome. Nat. Struct. Mol. Biol, 2009. 16(5): p. 564-571.
62. Reik, W., G. Kelsey, and J. Walter, Dissecting de novo methylation. Nat. Genet, 1999. 23(4): p. 380-382.
63. Bird, A., DNA methylation patterns and epigenetic memory. Genes and Development, 2002. 16(1): p. 6-21.
64. Watt, F. and P.L. Molloy, Cytosine methylation prevents binding to DNA of a HeLa cell transcription factor required for optimal expression of the adenovirus major late promoter. Genes and Development, 1988. 2(9): p. 1136-1143.
65. Ng, H.-H., et al., MBD2 is a transcriptional repressor belonging to the MeCP1 histone deacetylase complex. Nat. Genet, 1999. 23(1): p. 58-61.
66. Feng, Q. and Y. Zhang, The MeCP1 complex represses transcription through preferential binding, remodeling, and deacetylating methylated nucleosomes. Genes andDevelopment, 2001. 15(7): p. 827-832.
67. Strahl, B.D. and C.D. Allis, The language of covalent histone modifications. Nature, 2000. 403(6765): p. 41-45.
68. Vaquero, A., A. Loyola, and D. Reinberg, The constantly changing face of chromatin. Sci. Aging. Knowl. Environ, 2003. 2003(14).
69. Murray, K., The occurrence ε-N-methyl lysine in histones. Biochemistry, 1964. 3(1): p. 10-14.
70. Kouzarides, T., Chromatin Modifications and Their Function. Cell, 2007. 128(4): p. 693-705.
71. Zhou, W., X. Wang, and M.G. Rosenfeld, Histone H2A ubiquitination in transcriptional regulation and DNA damage repair. The International Journal of Biochemistry and Cell Biology, 2009. 41(1): p. 12-15.
72. Weake, V.M. and J.L. Workman, Histone Ubiquitination: Triggering Gene Activity. Molecular Cell, 2008. 29(6): p. 653-663.
73. Thomson, S., L.C. Mahadevan, and A.L. Clayton, MAP kinase-mediated signalling to nucleosomes and immediate-early gene induction. Seminars in Cell and DevelopmentalBiology, 1999. 10(2): p. 205-214.
74. Cheung, P., C.D. Allis, and P. Sassone-Corsi, Signaling to Chromatin through Histone Modifications. Cell, 2000. 103(2): p. 263-271.
75. Hochedlinger, K. and R. Jaenisch, Nuclear reprogramming and pluripotency. Nature, 2006. 441(7097): p. 1061-1067.
76. Xie, H., et al., Stepwise Reprogramming of B Cells into Macrophages. Cell, 2004. 117(5): p. 663-676.
77. Kondo, T. and M. Raff, Oligodendrocyte Precursor Cells Reprogrammed to Become Multipotential CNS Stem Cells. Science, 2000. 289(5485): p. 1754-1757.
78. Shen, C.-N., J.M.W. Slack, and D. Tosh, Molecular basis of transdifferentiation of pancreas to liver. Nat. Cell Biol, 2000. 2(12): p. 879-887.
79. Zhou, Q., et al., In vivo reprogramming of adult pancreatic exocrine cells to [bgr]-cells. Nature, 2008. 455(7213): p. 627-632.
80. Darabi, R. and R.C.R. Perlingeiro, Lineage-specific reprogramming as a strategy for cell therapy. Cell Cycle, 2008. 7(12): p. 1732-1737.
81. Cobaleda, C., W. Jochum, and M. Busslinger, Conversion of mature B cells into T cells by dedifferentiation to uncommitted progenitors. Nature, 2007. 449(7161): p. 473-477.
82. Lagarkova, M.A., et al., Diverse epigenetic profile of novel human embryonic stem cell lines. Cell Cycle, 2006. 5(4): p. 416-420.
83. Lister, R., et al., Human DNA methylomes at base resolution show widespread epigenomic differences. Nature, 2009. advance online publication.
84. Kimura, H., et al., Histone Code Modifications on Pluripotential Nuclei of Reprogrammed Somatic Cells. Mol. Cell. Biol., 2004. 24(13): p. 5710-5720.
85. Shiota, K., et al., Epigenetic marks by DNA methylation specific to stem, germ and somatic cells in mice. Genes. to Cells, 2002. 7(9): p. 961-969.
86. Lee, J.-H., S.R.L. Hart, and D.G. Skalnik, Histone deacetylase activity is required for embryonic stem cell differentiation. Genesis, 2004. 38(1): p. 32-38.
87. Bantignies, F. and G. Cavalli, Cellular memory and dynamic regulation of polycomb group proteins. Current Opinion in Cell Biology, 2006. 18(3): p. 275-283.
88. Choi, S.C., et al., 5-Azacytidine induces cardiac differentiation of P19 embryonic stem cells. Experimental and Molecular Medicine, 2004. 36(6): p. 515-523.
89. Snykers, S., et al., Role of epigenetics in liver-specific gene transcription, hepatocyte differentiation and stem cell reprogrammation. Journal of Hepatology, 2009. 51(1): p. 187-211.
90. Hsieh, J., et al., Histone deacetylase inhibition-mediated neuronal differentiation of multipotent adult neural progenitor cells. Proceedings of the National Academy ofSciences of the United States of America, 2004. 101(47): p. 16659-16664.
91. Hattori, N., et al., Epigenetic Control of Mouse Oct-4 Gene Expression in Embryonic Stem Cells and Trophoblast Stem Cells. J. Biol. Chem., 2004. 279(17): p. 17063-17069.
92. Odoricoa, J.S., D.S. Kaufmanb, and J.A. Thomson, Multilineage Differentiation from Human Embryonic Stem Cell Lines. Stem Cells, 2001. 19(3): p. 193-204.
93. Cowan, C.A., et al., Nuclear Reprogramming of Somatic Cells After Fusion with Human Embryonic Stem Cells. Science, 2005. 309: p. 1369-1373.
94. Freberg, C.T., et al., Epigenetic Reprogramming of OCT4 and NANOG Regulatory Regions by Embryonal Carcinoma Cell Extract. Mole. Biol. Cell, 2007. 18(5): p. 1543-1553.
95. Briggs, R. and T.J. King, Transplantation of Living Nuclei From Blastula Cells into Enucleated Frogs' Eggs. PNAS, 1952. 38(5): p. 455-463.
96. Wilmut, I., et al., Viable offspring derived from fetal and adult mammalian cells. Nature, 1997. 385: p. 810-813.
97. Wakayama, S., et al., Establishment of male and female nuclear transfer embryonic stem cell lines from different mouse strains and tissues. Biol. Reprod, 2005. 72(4): p. 932-6.
98. Wakayama, T., et al., Differentiation of embryonic stem cell lines generated from adult somatic cells by nuclear transfer. Science, 2001. 292(5517): p. 740-3.
99. Byrne, J.A., et al., Producing primate embryonic stem cells by somatic cell nuclear transfer. Nature, 2007. 450(7169): p. 497-502.
100. French, A.J., et al., Development of human cloned blastocysts following somatic cell nuclear transfer with adult fibroblasts. Stem Cells, 2008. 26(2): p. 485-93.
101. Heindryckx, B., et al., Embryo development after successful somatic cell nuclear transfer to in vitro matured human germinal vesicle oocytes. Hum. Reprod, 2007. 22(7): p. 1982-90.
102. Li, J., et al., Human embryos derived by somatic cell nuclear transfer using an alternative enucleation approach. Cloning StemCells, 2009. 11(1): p. 39-50.
103. Egli, D., et al., Developmental reprogramming after chromosome transfer into mitotic mouse zygotes. Nature, 2007. 447(7145): p. 679-85.
104. Zhao, J., et al., Significant improvement in cloning efficiency of an inbred miniature pig by histone deacetylase inhibitor treatment after somatic cell nuclear transfer. Biol Reprod, 2009. 81(3): p. 525-30.
105. Zhang, Y.H., et al., An epigenetic modifier results in improved in vitro blastocyst production after somatic cell nuclear transfer. Cloning and Stem Cells, 2007. 9(3): p. 357-363.
106. Enright, B.P., et al., Methylation and Acetylation Characteristics of Cloned Bovine Embryos from Donor Cells Treated with 5-aza-2′-Deoxycytidine.Biol. of Reprod., 2005. 72(4): p. 944-948.
107. Blelloch, R., et al., Reprogramming efficiency following somatic cell nuclear transfer is influenced by the differentiation and methylation state of the donor nucleus. Stem Cells, 2006. 24(9): p. 2007-13.
108. Lacham-Kaplan, O., H. Chy, and A. Trounson, Testicular cell conditioned medium supports differentiation of embryonic stem cells into ovarian structures containing oocytes. Stem Cells, 2006. 24(2): p. 266-73.
109. Kerkis, A., et al., In vitro differentiation of male mouse embryonic stem cells into both presumptive sperm cells and oocytes. Cloning Stem Cells, 2007. 9(4): p. 535-48.
110. Kato, Y., et al., Eight Calves Cloned from SomaticCells of a Single Adult Science, 1998. 282(5396): p. 2095-2098.
111. Wakayama, T. and R. Yanagimachi, Cloning of male mice from adult tail-tip cells. Nat.Gen., 1999. 22: p. 127-128.
112. Baguisi, A., et al., Production of goats by somatic cell nuclear transfer. Nat. Biotech., 1999. 17: p. 456-461.
113. Polejaeva, I.A., et al., Cloned pigs produced by nuclear transfer from adult somatic cells. Nature, 2000. 407: p. 86-90.
114. Shin, T., et al., Cell biology: A cat cloned by nuclear transplantation. Nature, 2002. 415: p. 859.
115. Chesné, P., et al., Cloned rabbits produced by nuclear transfer from adult somatic cells. Nat. Biotech., 2002. 20: p. 366-369.
116. Zhou, Q., et al., Generation of Fertile Cloned Rats by Regulating Oocyte Activation Science, 2003. 302(5648): p. 1179.
117. Galli, C., et al., Pregnancy: A cloned horse born to its dam twin. Nature, 2003. 424: p. 635.
118. Lee, B.C., et al., Dogs cloned from adult somatic cells. Nature, 2005. 436: p. 641.
119. Yang, B.Z., et al., An Inter-Subspecies Cloned Buffalo (Bubalus bubalis) Obtained by Transferring of Cryopreserved Embryos via Somatic Cell Nuclear Transfer. ReprodDomest. Anim, 2009.
120. Wani, N.A., et al., Production of the First Cloned Camel by Somatic Cell Nuclear Transfer.Biol. Reprod, 2009.
121. Lanza, R.P., et al., Cloning of an endangered species (Bos gaurus) using interspecies nuclear transfer. Cloning, 2000. 2(2): p. 79-90.
122. Oh, B.-C., et al., Production of Blastocysts after Intergeneric Nuclear Transfer of Goral (Naemorhedus goral) Somatic Cells into Bovine Oocytes. J. Vet. Med. Sci, 2006. 68(11): p. 1167-1171.
123. Kim, M.K., et al., Endangered wolves cloned from adult somatic cells. Cloning StemCells, 2007. 9(1): p. 130-7.
124. Jang, G., et al., Conservation of the Sapsaree (Canis familiaris), a Korean Natural Monument, using Somatic Cell Nuclear Transfer. J. Vet. Med. Sci, 2009. 71(9): p. 1217-20.
125. Rudenko, L. and J.C. Matheson, The US FDA and animal cloning: risk and regulatory approach. Theriogenology, 2007. 67(1): p. 198-206.
126. Takahashi, K. and S. Yamanaka, Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell, 2006. 126(4): p. 663-76.
127. Takahashi, K., et al., Induction of pluripotent stem cells from fibroblast cultures. Nat.Protoc, 2007. 2(12): p. 3081-9.
128. Wernig, M., et al., In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature, 2007. 448(7151): p. 318-324.
129. Maherali, N., et al., Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution. Cell Stem Cell, 2007. 1(1): p. 55-70.
130. Brambrink, T., et al., Sequential expression of pluripotency markers during direct reprogramming of mouse somatic cells. Cell Stem Cell, 2008. 2(2): p. 151-9.
131. Marson, A., et al., Wnt signaling promotes reprogramming of somatic cells to pluripotency. Cell Stem Cell, 2008. 3(2): p. 132-5.
132. Stadtfeld, M., et al., Defining molecular cornerstones during fibroblast to iPS cell reprogramming in mouse. Cell Stem Cell, 2008. 2(3): p. 230-40.
133. Hockemeyer, D., et al., A Drug-Inducible System for Direct Reprogramming of Human Somatic Cells to Pluripotency. Cell Stem Cell, 2008. 3: p. 346-353.
134. Zhang, J., et al., Functional cardiomyocytes derived from human induced pluripotent stem cells. Circ. Res, 2009. 104(4): p. e30-41.
135. Cai, J., et al., Dopaminergic Neurons Derived from Human Induced Pluripotent Stem Cells Survive and Integrate into 6-OHDA Lesioned Rats. Stem Cells Dev, 2009.
136. Karumbayaram, S., et al., Directed differentiation of human-induced pluripotent stem cells generates active motor neurons. Stem Cells, 2009. 27(4): p. 806-11.\
137. Zhang, D.H., et al., Highly efficient differentiation of human ES cells and iPS cells into mature pancreatic insulin-producing cells. Cell Research, 2009. 19(4): p. 429-438.
138. Stadtfeld, M., et al., Induced Pluripotent Stem Cells Generated Without Viral Integration. Science, 2008. 322(5903): p. 945-949.
139. Okita, K., et al., Generation of mouse induced pluripotent stem cells without viral vectors. Science, 2008. 322(5903): p. 949-53.
140. Yu, J., Human induced pluripotent stem cells free of vector and transgene sequences. Science, 2009. 324(5932): p. 1266-1266.
141. Woltjen, K., et al., piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature, 2009. 458(7239): p. 766-70.
142. Zhou, H., et al., Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell, 2009. 4(5): p. 381-4.
143. Kim, D., et al., Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. Cell Stem Cell, 2009. 4(6): p. 472-6.
144. Huangfu, D., et al., Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds. Nat. Biotech., 2008. 26: p. 795-797.
145. Shi, Y., et al., A combined chemical and genetic approach for the generation of induced pluripotent stem cells (vol 2, pg 525, 2008). Cell Stem Cell, 2008. 3(1): p. 119-119.
146. Chin, M.H., et al., Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures. Cell Stem Cell, 2009. 5(1): p. 111-23.
147. Wilson, K.D., et al., MicroRNA profiling of human-induced pluripotent stem cells. Stem Cells Dev, 2009. 18(5): p. 749-58.
148. Marchetto, M.C., et al., Transcriptional signature and memory retention of human-induced pluripotent stem cells. PLoS ONE, 2009. 4(9): p. e7076.
149. Osafune, K., et al., Marked differences in differentiation propensity among human embryonic stem cell lines. Nat. Biotechnol, 2008. 26(3): p. 313-315.
150. Nagy, A., et al., Derivation of completely cell culture-derived mice from early-passage embryonic stem cells. Proc. Natl. Acad. Sci. USA, 1993. 90(18): p. 8424-8.
151. Boland, M.J., et al., Adult mice generated from induced pluripotent stem cells. Nature, 2009. 461(7260): p. 91-4.
152. Kang, L., et al., iPS Cells Can Support Full-Term Development of Tetraploid Blastocyst-Complemented Embryos. Cell Stem Cell, 2009. 5(2): p. 135-138.
153. Chan, E.M., et al., Live cell imaging distinguishes bona fide human iPS cells from partially reprogrammed cells. Nat. Biotechnol, 2009. 27(11): p. 1033-7.
154. Sumer, H., et al., Reprogramming of somatic cells after fusion with iPS and ntES cells. Stem Cells Dev, 2009.
155. Hacein-Bey-Abina, S., et al., Sustained Correction of X-Linked Severe Combined Immunodeficiency by ex Vivo Gene Therapy. N. Engl. J. Med, 2002. 346: p. 1185-1193.
156. Hacein-Bey-Abina, S., et al., A Serious Adverse Event after Successful Gene Therapy for X-Linked Severe Combined Immunodeficiency. N. Engl. J. Med, 2003. 348(3): p. 255-256.
157. Vallier, L., et al., Enhancing and diminishing gene function in human embryonic stem cells. Stem Cells, 2004. 22(1): p. 2-11.
158. VandenDriessche, T., et al., Emerging potential of transposons for gene therapy and generation of induced pluripotent stem cells. Blood, 2009. 114(8): p. 1461-8.
159. Björklund, L.M., et al., Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model. PNAS, 2002. 99(4): p. 2344-2349.
160. Schuldiner, M., J. Itskovitz-Eldor, and N. Benvenisty, Selective ablation of human embryonic stem cells expressing a "suicide" gene. Stem Cells, 2003. 21(3): p. 257-65.
161. Kroon, E., et al., Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo. Nat. Biotech., 2008. 26: p. 443-452.
162. Swistowski, A., et al., Xeno-free defined conditions for culture of human embryonic stem cells, neural stem cells and dopaminergic neurons derived from them. PLoS ONE, 2009. 4(7): p. e6233.
163. Wernig, M., et al., Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease. PNAS, 2008. 105(15): p. 5856-5861.
164. Hanna, J., et al., Treatment of Sickle Cell Anemia Mouse Model with iPS Cells Generated from Autologous Skin. Science, 2007. 318(5858): p. 1920-1923.
165. Schreuder, G.M.T., et al., The HLA Dictionary 2001: a summary of HLA-A, -B, -C, -DRB1/3/4/5 and -DQB1 alleles and their association with serologically defined HLA-A, -B, -C, -DR and -DQ antigens. Eur. J. Immunogenet, 2002. 28: p. 565-596.
166. Drukker, M., et al., Characterization of the expression of MHC proteins in human embryonic stem cells. Proc. Natl. Acad. Sci. USA, 2002. 99(15): p. 9864-9.
167. Ramirez, M.A., et al., Inadvertent presence of pluripotent cells in monolayers derived from differentiated embryoid bodies. Int. J. Dev. Biol, 2007. 51(5): p. 397-407.
168. Choo, A.B., et al., Selection against undifferentiated human embryonic stem cells by a cytotoxic antibody recognizing podocalyxin-like protein-1. Stem Cells, 2008. 26(6): p. 1454-63.